These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 14007826)

  • 1. [The binding of 2-sul-fanilamido-5-methoxypyrimidine on protein and its level in the serum, tissue, cerebrospinal fluid and bile].
    WOEHLER F; OTTE W; JUNG H
    Arzneimittelforschung; 1961 Aug; 11():736-9. PubMed ID: 14007826
    [No Abstract]   [Full Text] [Related]  

  • 2. [The binding of long-acting sulfonamides on serum proteins. 2].
    SCHOLTAN W
    Arzneimittelforschung; 1961 Aug; 11():707-20. PubMed ID: 13909147
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the serum protein binding and renal elimination of isomeric sulfonamides (5-sulfanilamide-3-ethyl-1,2,4-thiodiazol and 5-sulfanilamido-2-ethyl-1,3,4-thiodiazol)].
    Irmscher K; Gabe D; Jahnke K; Scholtan W
    Arzneimittelforschung; 1966 Aug; 16(8):1019-25. PubMed ID: 6014883
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fate and excretion of depot sulfonamides. 1. Binding on plasma proteins].
    GARN FW; KIMBEL KH
    Arzneimittelforschung; 1961 Aug; 11():701-7. PubMed ID: 13897002
    [No Abstract]   [Full Text] [Related]  

  • 5. A quantitative immunochemical method for determining serum and cerebrospinal fluid proteins.
    GOODMAN M; VULPE M
    World Neurol; 1961 Jul; 2():589-601. PubMed ID: 13707049
    [No Abstract]   [Full Text] [Related]  

  • 6. [On protein binding, blood, cerebrospinal fluid and tissue levels of some new sulfonamides].
    WOEHLER F; SPECKMANN L
    Arzneimittelforschung; 1960 Nov; 10():859-69. PubMed ID: 13786162
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood and cerebrospinal fluid levels of sulfamethoxypyridazine after intravenous administration in children.
    SMITH GF; HEFFNER RW; CLEVELAND WW; LAWSON RB
    Antibiot Annu; 1958-1959; 6():69-74. PubMed ID: 13637710
    [No Abstract]   [Full Text] [Related]  

  • 8. A different view on bilirubin binding.
    Wennberg RP; Ahlfors CE
    Pediatrics; 2006 Aug; 118(2):846-7. PubMed ID: 16882854
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tripyraphene and the sulfonamide-protein bonds].
    PICCININI F
    Boll Soc Ital Biol Sper; 1961 Feb; 37():112-4. PubMed ID: 13735422
    [No Abstract]   [Full Text] [Related]  

  • 10. Competition between sulfonamides and tetracyclines in the binding with serum proteins.
    Genazzani E; Bononi LJ; Pagnini G; DiCarlo R
    Antimicrob Agents Chemother (Bethesda); 1965; 5():192-6. PubMed ID: 5883425
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-acting sulfonamides: in vivo correlation in man of protein binding, serum concentration and antimicrobial activity.
    Batterman RC; Tauber LF; Bell ME
    Curr Ther Res Clin Exp; 1966 Mar; 8(3):75-84. PubMed ID: 4956579
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease.
    Korolainen MA; Pirttilä T
    Acta Neurol Scand; 2009 Jan; 119(1):32-8. PubMed ID: 18547271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term sulfonamides].
    Struller T
    Pharm Acta Helv; 1965 Jan; 40(1):1-18. PubMed ID: 5858666
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacology of sulfaethoxypyridazine in the heifer.
    Linkenheimer WH; Stolzenberg SJ; Wozniak LA
    J Pharmacol Exp Ther; 1965 Aug; 149(2):280-7. PubMed ID: 5831049
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interaction of the new gestagen compound 17alpha-acetoxy-3beta-butanoyloxy-6-methylpregna-4,6-dien-20-one with human blood proteins and calf embryo serum].
    Vetchinkina VB; Semeĭkin AV; Rzheznikov VM; Shimanovskiĭ NL
    Eksp Klin Farmakol; 2008; 71(2):36-9. PubMed ID: 18488905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the determination of protein binding by sulfonamides by means of the ultrafilter method].
    vom BRUCK CG; KUHNE J
    Arzneimittelforschung; 1962 Nov; 12():1116-9. PubMed ID: 14016137
    [No Abstract]   [Full Text] [Related]  

  • 17. The binding of plutonium to serum proteins in vitro.
    Turner GA; Taylor DM
    Radiat Res; 1968 Oct; 36(1):22-30. PubMed ID: 17387923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid-vapor interfacial tension of blood plasma, serum and purified protein constituents thereof.
    Krishnan A; Wilson A; Sturgeon J; Siedlecki CA; Vogler EA
    Biomaterials; 2005 Jun; 26(17):3445-53. PubMed ID: 15621233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of cisplatin binding sites in human serum proteins using hyphenated multidimensional liquid chromatography and ESI tandem mass spectrometry.
    Will J; Wolters DA; Sheldrick WS
    ChemMedChem; 2008 Nov; 3(11):1696-707. PubMed ID: 18855968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences among techniques for high-abundant protein depletion.
    Zolotarjova N; Martosella J; Nicol G; Bailey J; Boyes BE; Barrett WC
    Proteomics; 2005 Aug; 5(13):3304-13. PubMed ID: 16052628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.